Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence

Abrams, 1994, New words for old: lower urinary tract symptoms for “prostatism”, BMJ, 308, 929, 10.1136/bmj.308.6934.929 Abrams, 2002, The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society, Neurourol Urodyn, 21, 167, 10.1002/nau.10052 Cózar Olmo, 2012, Consensus on the clinical impact of the new scientific evidence available on benign prostatic hyperplasia, Actas Urol Esp, 36, 265, 10.1016/j.acuroe.2012.08.011 De la Rosette, 2001, EAU guidelines on benign prostatic hyperplasia (BPH), Eur Urol, 40, 256, 10.1159/000049784 Gravas S, Bachmann A, Descazeaud A, Drake M, Gratzke C, Madersbache S, et al. EAU Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) – Update 2014. Available from: http://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/?type=archive [accessed 20.10.15]. Fernández Pérez, 2009, Prevalencia de síntomas del tracto urinario inferior relacionadoscon la hiperplasia benigna de próstata. Estudio de 1.804 hombres de 40 años o más residentes en Madrid durante 1999–2000, Actas Urol Esp, 33, 43, 10.1016/S0210-4806(09)74001-X Irwin, 2006, Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study, Eur Urol, 50, 1306, 10.1016/j.eururo.2006.09.019 Irwin, 2009, Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder, Eur Urol, 56, 14, 10.1016/j.eururo.2009.02.026 Coyne, 2009, The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study, BJU Int, 104, 352, 10.1111/j.1464-410X.2009.08427.x Martínez Agulló, 2009, Prevalencia de la incontinencia urinaria y vejiga hiperactiva en la población española. Resultados del estudio EPICC, Actas Urol Esp, 33, 159, 10.1016/S0210-4806(09)74117-8 Filson, 2013, The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis, J Urol, 190, 2153, 10.1016/j.juro.2013.05.058 Saito, 1999, A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakisuria and/or urinary incontinence, Japn J Urol Surg, 12, 525 Athanasopoulos, 2003, Combination treatment with an α-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study, J Urol, 169, 2253, 10.1097/01.ju.0000067541.73285.eb Kaplan, 2006, Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial, JAMA, 296, 2319, 10.1001/jama.296.19.2319 MacDiarmid, 2008, Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study, Mayo Clin Proc, 83, 1002, 10.4065/83.9.1002 Kaplan, 2009, Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency, J Urol, 182, 2825, 10.1016/j.juro.2009.08.023 Lee, 2005, J Urol, 174, 1334, 10.1097/01.ju.0000173630.94559.fd Yang, 2007, Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study, Chin Med J (Engl), 120, 370, 10.1097/00029330-200703010-00004 Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, et al. Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). Available from: https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/ [updated March 2015; accessed 11.12.15]. Van Kerrebroeck, 2013, Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN), Eur Urol, 64, 398, 10.1016/j.eururo.2013.03.031 Van Kerrebroeck, 2013, Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial, Eur Urol, 64, 1003, 10.1016/j.eururo.2013.07.034 Drake, 2015, Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE study and NEPTUNE II open-label extension, Eur Urol, 67, 262, 10.1016/j.eururo.2014.07.013 Volutsa. Ficha técnica. Available from: http://www.aemps.gob.es/cima/pdfs/es/ft/78928/FT_78928.pdf [accessed 6.10.15]. García-Segui, 2012, Estudio comparativo entre adenomectomía laparoscópica extraperitoneal y abierta, Actas Urol Esp, 36, 110, 10.1016/j.acuro.2011.09.002 Bachmann, 2015, A European multicenter randomized noninferiority trial comparing 180W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study, J Urol, 193, 570, 10.1016/j.juro.2014.09.001 Benejam-Gual, 2014, Estudio multicéntrico de costes de 2 técnicas quirúrgicas: láser GreenLight XPS 180W vs. resección transuretral de la próstata, Actas Urol Esp, 38, 373, 10.1016/j.acuro.2013.10.011 Soto-Mesa, 2015, Enucleación prostática con láser holmio y adenomectomía prostática retropúbica: análisis de morbilidad y consideraciones anestésicas, Actas Urol Esp, 39, 535, 10.1016/j.acuro.2015.03.005 Juaneda, 2016, Análisis comparativo entre la enucleación prostática con láser de holmio y la adenomectomía laparoscópica en el tratamiento de adenomas prostáticos mayores de 100g, Actas Urol Esp, 40, 43, 10.1016/j.acuro.2015.05.010 Razzaghi, 2014, Diode Laser (980nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: Randomized clinical trial with 2-year follow-up, Urology, 84, 526, 10.1016/j.urology.2014.05.027